Sustainability Is Part Of Our Daily Business

By Luca Dalla Torre, Former Chief Legal and Sustainability Office

Sustainability is becoming a business imperative across the pharmaceutical value chain, requiring organizations to balance environmental responsibility, operational performance, and long-term growth. At Siegfried, sustainability is embedded into daily decision-making through measurable goals, governance structures, and incentives that link environmental, social, and governance (ESG) performance to business outcomes.

Recent progress includes the validation of ambitious science-based emissions reduction targets, positioning the company among the first CDMOs with validated net-zero commitments. Efforts to reduce carbon emissions, improve energy efficiency, increase renewable energy adoption, and recover solvents are helping drive meaningful improvements across operations while supporting customers' sustainability objectives.

Looking ahead, the focus is shifting from target setting to execution. Decarbonization initiatives, enhanced data transparency, and deeper collaboration with suppliers and customers will play a central role in addressing Scope 3 emissions and advancing sustainability across the broader value chain. Explore how strategic planning, operational discipline, and cross-industry partnerships are helping transform sustainability ambitions into measurable action.